1. Home
  2. PBM vs MBIO Comparison

PBM vs MBIO Comparison

Compare PBM & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • MBIO
  • Stock Information
  • Founded
  • PBM 1994
  • MBIO 2015
  • Country
  • PBM Canada
  • MBIO United States
  • Employees
  • PBM N/A
  • MBIO N/A
  • Industry
  • PBM
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • MBIO Health Care
  • Exchange
  • PBM NYSE
  • MBIO Nasdaq
  • Market Cap
  • PBM 5.3M
  • MBIO 7.3M
  • IPO Year
  • PBM N/A
  • MBIO N/A
  • Fundamental
  • Price
  • PBM $1.35
  • MBIO $2.71
  • Analyst Decision
  • PBM
  • MBIO Strong Buy
  • Analyst Count
  • PBM 0
  • MBIO 1
  • Target Price
  • PBM N/A
  • MBIO $100.00
  • AVG Volume (30 Days)
  • PBM 438.0K
  • MBIO 403.2K
  • Earning Date
  • PBM 02-02-2025
  • MBIO 03-10-2025
  • Dividend Yield
  • PBM N/A
  • MBIO N/A
  • EPS Growth
  • PBM N/A
  • MBIO N/A
  • EPS
  • PBM N/A
  • MBIO N/A
  • Revenue
  • PBM N/A
  • MBIO N/A
  • Revenue This Year
  • PBM N/A
  • MBIO N/A
  • Revenue Next Year
  • PBM N/A
  • MBIO N/A
  • P/E Ratio
  • PBM N/A
  • MBIO N/A
  • Revenue Growth
  • PBM N/A
  • MBIO N/A
  • 52 Week Low
  • PBM $1.15
  • MBIO $2.40
  • 52 Week High
  • PBM $323.25
  • MBIO $74.50
  • Technical
  • Relative Strength Index (RSI)
  • PBM 40.15
  • MBIO 29.29
  • Support Level
  • PBM $1.15
  • MBIO $2.40
  • Resistance Level
  • PBM $1.47
  • MBIO $2.95
  • Average True Range (ATR)
  • PBM 0.13
  • MBIO 0.39
  • MACD
  • PBM 0.03
  • MBIO 0.12
  • Stochastic Oscillator
  • PBM 36.65
  • MBIO 11.82

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: